# Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/head-to-head-evaluation-of-second-generation-alk-inhibitors-brigatinib-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Enric Carcereny,Alonso Fernández-Nistal,Araceli López,Carmen Montoto,Andrea Naves,Cristina Segú-Vergés,Mireia Coma,Guillem Jorba,Baldomero Oliva,José Manuel Mas |
| Citations | 24 |
| DOI | 10.18632/oncotarget.27875 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/27875/pdf/ |
| OpenAlex ID | https://openalex.org/W3132241918 |
| PMID | 33659043 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Carmen Montoto](https://scholariq.org/researchers/carmen-montoto/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.